Compelling evidence indicates that NOD1 and NOD2 polymorphisms are involved in a great number of immunologic and inflammatory diseases, including Crohn’s disease (CD), Blau syndrome, Behcet’s syndrome, ulcerative colitis (UC), atopic diseases, and early-onset sarcoidosis (EOS) (193, 194). This evidence concerns the gene NOD2 and Blau syndrome.